Finance

Lists
4534:TYO
Mochida Pharmaceutical Co Ltd
3 090,00 JP¥
0,00%
(0,00) 1D
5-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4534...
Mkt. cap
112,45 млд
Avg. vol.
43,90 миң
Volume
0,00
Dividend
2,59%
Quarterly dividend
20 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
11,92
52-wk high
3 965 JP¥
52-wk low
2 929 JP¥
EPS
259 JP¥
Shares outstanding
19,85 млн
No. of employees
1 миң
Mkt. cap
112,45 млд
Avg. vol.
43,90 миң
Volume
0,00
Dividend
2,59%
Quarterly dividend
20 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
11,92
52-wk high
3 965 JP¥
52-wk low
2 929 JP¥
EPS
259 JP¥
Shares outstanding
19,85 млн
No. of employees
1 миң
News stories
From web sources and news partners
Profile
Mochida Pharmaceutical Co., Ltd is a Japanese pharmaceutical company. One of its products is the antidepressant setiptiline. Wikipedia
About Mochida Pharmaceutical Co Ltd
CEO-
Employees1,48 миң
Founded1945-ж., 28-апр.
HeadquartersShinjuku City, Tokyo, Япония
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
28,35 млд
32,50 млд
29,46 млд
31,72 млд
Cost of goods sold
15,13 млд
17,50 млд
15,06 млд
17,03 млд
Cost of revenue
15,13 млд
17,50 млд
15,06 млд
17,03 млд
Research and development expenses
-
-
12,16 млд
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,83 млд
12,45 млд
-376,00 млн
11,12 млд
Operating expense
10,83 млд
12,45 млд
11,78 млд
11,12 млд
Total operating expenses
25,96 млд
29,94 млд
26,84 млд
28,15 млд
Operating income
2,40 млд
2,56 млд
2,62 млд
3,56 млд
Other non operating income
31,00 млн
-67,00 млн
12,00 млн
34,00 млн
EBT including unusual items
2,40 млд
3,17 млд
2,82 млд
4,86 млд
EBT excluding unusual items
2,40 млд
3,17 млд
2,85 млд
4,19 млд
Income tax expense
435,00 млн
681,00 млн
1,26 млд
1,69 млд
Effective tax rate
18,15%
21,50%
44,72%
34,68%
Other operating expenses
-
-
-
-
Net income
1,96 млд
2,49 млд
1,56 млд
3,18 млд
Net profit margin
6,92%
7,65%
5,30%
10,02%
Earnings per share
-
-
-
-
Interest and investment income
42,00 млн
232,00 млн
42,00 млн
297,00 млн
Interest expense
-1,00 млн
-29,00 млн
-42,00 млн
-43,00 млн
Net interest expenses
41,00 млн
203,00 млн
-
254,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
3,11 млд
-
3,37 млд
4,31 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору